Literature DB >> 3928682

Hydrogen peroxide from cellular metabolism of cystine. A requirement for lysis of murine tumor cells by vernolepin, a glutathione-depleting antineoplastic.

B A Arrick, W Griffo, Z Cohn, C Nathan.   

Abstract

The sesquiterpene lactone antineoplastic vernolepin acutely depletes murine tumor cell glutathione (GSH), and lyses the cells by an unknown mechanism that is enhanced synergistically by inhibition of GSH synthesis with buthionine sulfoximine (BSO) (Arrick et al. 1983. J. Clin. Invest. 71:258). We found here that lysis of P815 mastocytoma cells by vernolepin, with or without BSO, required cystine in the culture medium. Addition of catalase markedly suppressed vernolepin-mediated cytolysis in cystine-containing media, suggesting the involvement of hydrogen peroxide in the cytolytic action of vernolepin. Consistent with this, inhibition of tumor cell glutathione disulfide reductase with 1,3-bis(2-chloroethyl)-1-nitrosourea or inhibition of endogenous catalase with aminotriazole synergistically augmented cytolysis by vernolepin. Moreover, H2O2 was released by suspensions of P815 cells in cystine-containing buffer (63 pmol/10(6) cells X h). Omission of cystine reduced the rate of H2O2 accumulation 10-fold. No H2O2 was detected without cells. Cytolysis by vernolepin could be restored in cystine-deficient medium by several other disulfides, themselves noncytolytic, such as disulfiram and oxidized Captopril, as well as by cysteine. In contrast, withholding two other essential amino acids (leucine or tryptophan) or adding cycloheximide did not interfere with cytolysis by vernolepin. These results suggest that cellular uptake of disulfides of physiologic and pharmacologic interest may be followed by their intracellular reduction and autooxidation with generation of H2O2. This previously unrecognized source of intracellular oxidant stress may be an important component of injury to GSH-depleted cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3928682      PMCID: PMC423862          DOI: 10.1172/JCI112008

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  44 in total

1.  gamma-Cystathionase in normal and leukemic cells.

Authors:  L M Glode; H L Greene; I Bikel
Journal:  Cancer Treat Rep       Date:  1979-06

2.  Glutathione biosynthesis in murine L5178Y lymphoma cells.

Authors:  A E Brodie; J Potter; W W Ellis; M C Evenson; D J Reed
Journal:  Arch Biochem Biophys       Date:  1981-09       Impact factor: 4.013

3.  Glutathione depletion sensitizes tumor cells to oxidative cytolysis.

Authors:  B A Arrick; C F Nathan; O W Griffith; Z A Cohn
Journal:  J Biol Chem       Date:  1982-02-10       Impact factor: 5.157

4.  Involvement of the cystathionine pathway in the biosynthesis of glutathione by isolated rat hepatocytes.

Authors:  P W Beatty; D J Reed
Journal:  Arch Biochem Biophys       Date:  1980-10-01       Impact factor: 4.013

5.  Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine).

Authors:  O W Griffith; A Meister
Journal:  J Biol Chem       Date:  1979-08-25       Impact factor: 5.157

6.  Unique characteristics of rat spleen lymphocyte, L1210 lymphoma and HeLa cells in glutathione biosynthesis from sulfur-containing amino acids.

Authors:  A E Brodie; J Potter; D J Reed
Journal:  Eur J Biochem       Date:  1982-03

7.  H2O2 production, modification of the glutathione status and methemoglobin formation in red blood cells exposed to diethyldithiocarbamate in vitro.

Authors:  P M Sinet; P Garber; H Jerome
Journal:  Biochem Pharmacol       Date:  1982-02-15       Impact factor: 5.858

8.  Role of hydrogen peroxide in neutrophil-mediated destruction of cultured endothelial cells.

Authors:  S J Weiss; J Young; A F LoBuglio; A Slivka; N F Nimeh
Journal:  J Clin Invest       Date:  1981-09       Impact factor: 14.808

9.  Antitumor effects of hydrogen peroxide in vivo.

Authors:  C F Nathan; Z A Cohn
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

10.  Tumor cell anti-oxidant defenses. Inhibition of the glutathione redox cycle enhances macrophage-mediated cytolysis.

Authors:  C F Nathan; B A Arrick; H W Murray; N M DeSantis; Z A Cohn
Journal:  J Exp Med       Date:  1981-04-01       Impact factor: 14.307

View more
  6 in total

1.  A therapeutic trial with N-acetylcysteine in subjects with hereditary glutathione synthetase deficiency (5-oxoprolinuria).

Authors:  J Mårtensson; J Gustafsson; A Larsson
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

2.  Effects of reagent and cell-generated hydrogen peroxide on the properties of low density lipoprotein.

Authors:  R R Montgomery; C F Nathan; Z A Cohn
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

3.  Secretion of pyruvate. An antioxidant defense of mammalian cells.

Authors:  J O'Donnell-Tormey; C F Nathan; K Lanks; C J DeBoer; J de la Harpe
Journal:  J Exp Med       Date:  1987-02-01       Impact factor: 14.307

4.  Regulation of System xc(-) by Pharmacological Manipulation of Cellular Thiols.

Authors:  Rebecca Albano; Nicholas J Raddatz; Julie Hjelmhaug; David A Baker; Doug Lobner
Journal:  Oxid Med Cell Longev       Date:  2015-04-09       Impact factor: 6.543

5.  Bi-functional oxidized dextran-based hydrogel inducing microtumors: An in vitro three-dimensional lung tumor model for drug toxicity assays.

Authors:  Dhaval Kedaria; Rajesh Vasita
Journal:  J Tissue Eng       Date:  2017-06-30       Impact factor: 7.813

6.  Zanvil Alexander Cohn 1926-1993.

Authors:  R M Steinman; C L Moberg
Journal:  J Exp Med       Date:  1994-01-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.